| PRD_000605 | Name: | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide | Formula: | C21 H30 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000606 | Name: | (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide | Formula: | C21 H30 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000607 | Name: | (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide | Formula: | C22 H32 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000608 | Name: | D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide | Formula: | C22 H27 N3 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000609 | Name: | D-phenylalanyl-N-benzyl-L-prolinamide | Formula: | C21 H25 N3 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000610 | Name: | 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide | Formula: | C21 H30 Cl N3 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000611 | Name: | N-acetyl-3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide | Formula: | C23 H32 Cl N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000612 | Name: | N-(CARBOXYMETHYL)-3-CYCLOHEXYL-D-ALANYL-N-({4-[(E)-AMINO(IMINO)METHYL]-1,3-THIAZOL-2-YL}METHYL)-L-PROLINAMIDE | Formula: | C21 H32 N6 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000613 | Name: | N-(CARBOXYMETHYL)-3-CYCLOHEXYL-D-ALANYL-N-({5-[(E)-AMINO(IMINO)METHYL]THIEN-2-YL}METHYL)-L-PROLINAMIDE | Formula: | C22 H33 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000616 | Name: | 3-cyclohexyl-D-alanyl-L-prolyl-N~2~-methyl-L-arginine | Formula: | C21 H38 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000617 | Name: | (1S,7S)-7-amino-N-[(2R,3S)-7-amino-1-(cyclohexylamino)-2-hydroxy-1-oxoheptan-3-yl]-7-benzyl-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C28 H44 N6 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000618 | Name: | (1S,7S)-7-amino-7-benzyl-N-[(1S)-4-carbamimidamido-1-{(1S)-1-hydroxy-2-oxo-2-[(2-phenylethyl)amino]ethyl}butyl]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | Formula: | C30 H42 N8 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000619 | Name: | (1S,7S)-7-amino-7-benzyl-N-{(1S)-4-carbamimidamido-1-[(S)-hydroxy(1,3-thiazol-2-yl)methyl]butyl}-8-oxohexahydro-1H-pyra
zolo[1,2-a]pyridazine-1-carboxamide | Formula: | C24 H34 N8 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000621 | Name: | D-phenylalanyl-N-{(1S)-1-[(S)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-carbamimidamidobutyl}-L-prolinamide | Formula: | C27 H35 N7 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000622 | Name: | amino{[(4S)-4-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)-5-oxo-5-{(2R)-2-[3-oxo-3-(1,3-thiazol-2-yl)propyl]pip
eridin-1-yl}pentyl]amino}methaniminium | Formula: | C29 H40 N7 O4 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000623 | Name: | N-methyl-D-phenylalanyl-N-{(1S)-4-carbamimidamido-1-[(6-carboxy-1,3-benzothiazol-2-yl)carbonyl]butyl}-L-prolinamide | Formula: | C29 H35 N7 O5 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000628 | Name: | [N-[N-(4-METHOXY-2,3,6-TRIMETHYLPHENYLSULFONYL)-L-ASPARTYL]-D-(4-AMIDINO-PHENYLALANYL)]-PIPERIDINE | Formula: | C29 H39 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000630 | Name: | N~2~-{(2R)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-glutaminyl-L-aspartamide | Formula: | C21 H31 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000632 | Name: | (1R,2S,3R,1S',1S")Phosphoric acid mono(4-{2-[1-(1,2-dicarbamoylethylcarbamoyl)-3-carbamoylpropylcarbamoyl]-3-methylcarbamoylcyclopropyl}phenyl) ester | Formula: | C22 H32 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000633 | Name: | N~2~-({(1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropyl}carbonyl)-D-glutaminyl-D-aspartamide | Formula: | C21 H29 N6 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000634 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-isoleucyl-L-aspartamide | Formula: | C22 H34 N5 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000635 | Name: | N-{(2S)-4-(methylamino)-4-oxo-2-[4-(phosphonooxy)benzyl]butanoyl}-L-alpha-glutamyl-L-aspartamide | Formula: | C21 H30 N5 O11 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000638 | Name: | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L-LEUCYL-L-TRYPTOPHAN | Formula: | C23 H34 N3 O10 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000639 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID METHYL ESTER | Formula: | C29 H47 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000640 | Name: | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2-(5,5,5-TRIFLUORO-3-HYDROXY-4-{3-METHYL-2-[3-METHYL-2-(3-METHYL-BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}-PENTANOYLAMINO)-PROPIONYLAMINO]-PENTANOIC ACID | Formula: | C28 H45 F6 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|